Clinical Trials Directory

Trials / Completed

CompletedNCT02611115

Optimizing Protocols for the Individual Patient in CT Pulmonary Angiography.

Optimizing Tube Voltage Settings and Injection Parameters for the Individual Patient in CT Pulmonary Angiography.

Status
Completed
Phase
Study type
Observational
Enrollment
235 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Computed tomographic pulmonary angiography (CTPA) is considered the gold standard for the diagnosis of pulmonary embolism (PE). PE is a potentially fatal disease in which a thrombus is lodged into a pulmonary artery blocking blood flow and potentially leading to respiratory distress, acute right cardiac failure or death. Therefore early and correct diagnosis is crucial. The diagnostic and clinical value of CTPA has already been firmly substantiated. Unfortunately up to 7.3% of PE scans are still deemed to be non-diagnostic, for example due to insufficient contrast enhancement in the target arteries. Therefore future research should focus on two important aspects of CT imaging. On the one hand optimal enhancement for the individual patient, on the other hand preventing additional risk of CT imaging - namely contrast induced nephropathy (CIN) and radiation risk. Thus the purpose of our study will be to optimize radiation dose settings (e.g. tube voltage, tube current) and CM application for the individual patient in CTPA.

Conditions

Timeline

Start date
2015-09-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2015-11-20
Last updated
2017-10-05

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02611115. Inclusion in this directory is not an endorsement.